Eventide Asset Management »

Aeglea Biotherapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $18M 202k 88.79

More positions owned by Eventide Asset Management

Guardant Health (GH)
Lam Research Corp Com New (LRCX)
Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Mirum Pharmaceuticals (MIRM)
Asml Hldg Nv N Y Registry Shs (ASML)
Targa Res Corp (TRGP)
Old Dominion Freight Line (ODFL)
Ge Vernova (GEV)
United Rentals (URI)
Argenx Se Sponsored Adr (ARGX)
Scholar Rock Hldg Corp (SRRK)
Irhythm Technologies (IRTC)
Kla Corp Com New (KLAC)
Beta Bionics (BBNX)

View all positions for Eventide Asset Management

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics